Showing results (1881-1890 of 2,338) with videos related to

Sort By:
Pageof 234
Physical Review Letters|August 19, 2024
Measurement of the Gamma-Ray-to-Neutron Branching Ratio for the Deuterium-Tritium Reaction in Magnetic Confinement Fusion PlasmasA Dal Molin, G Marcer, M Nocente, et al.
Research Square|April 8, 2025
SMARCB1 missense mutants disrupt SWI/SNF complex stability and remodeling activityGarrett W Cooper, Benjamin P Lee, Won Jun Kim, et al.
Obesity Surgery|July 4, 2001
Laparoscopic Italian experience with the Lap-BandL Angrisani, M Alkilani, N Basso, et al.
Cancer Discovery|June 15, 2013
Systematic interrogation of 3q26 identifies TLOC1 and SKIL as cancer driversDaniel Hagerstrand, Alexander Tong, Steven E Schumacher, et al.
Frontiers in Medicine|June 10, 2022
Early Spondyloarthritis Clinic: Organizational Improvements in the Patient JourneySalvatore D'Angelo, Antonella Afeltra, Fabiola Atzeni, et al.
Rheumatology (Oxford, England)|February 18, 2026
The use of non-TNF targeted biologics in Behçet's Disease: Real-life data from the International AIDA Network Behçet's Disease RegistryGizem Sevik, Giuseppe Lopalco, Florenzo Iannone, et al.
Parkinsonism & Related Disorders|November 29, 2025
Retinal structural changes in Parkinson's disease: differences in pRNFL thickness between GBA1-associated and idiopathic casesGiacomo Portaro, Michelangelo Giacomelli, Sara Grisanti, et al.
Rheumatology International|June 5, 2026
Clinical associations and related factors of metabolic syndrome in systemic sclerosis: results from an observational multicenter study of GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale)Vasiliki Liakouli, Giulio Forte, Piero Ruscitti, et al.
Cell|May 29, 2012
Identification of drugs including a dopamine receptor antagonist that selectively target cancer stem cellsEleftherios Sachlos, Ruth M Risueño, Sarah Laronde, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 19, 2018
Immediate Versus Deferred Switching From a Boosted Protease Inhibitor-based Regimen to a Dolutegravir-based Regimen in Virologically Suppressed Patients With High Cardiovascular Risk or Age ≥50 Years: Final 96-Week Results of the NEAT022 StudyJosé M Gatell, Lambert Assoumou, Graeme Moyle, et al.
Pageof 234